11 results
Pulmonary and Non-Pulmonary Causes of ARDS #Diagnosis #EM #PCC #ARDS #Differential #Algorithm #Pulmonary #NonPulmonary #Causes #Ddxof
Pulmonary and Non-Pulmonary ... ARDS #Diagnosis #EM ... #PCC #ARDS #Differential ... #Algorithm #Pulmonary ... NonPulmonary #Causes #Ddxof
Causes of Dyspnea by System #Diagnosis #EM #IM #PCC #Dyspnea #ShortnessOfBreath #Differential #Algorithm #Ddxof
System #Diagnosis #EM ... #IM #PCC #Dyspnea ... #Differential #Algorithm ... #Ddxof
Pleural Effusion - Workup, Diagnostic Algorithm #Diagnosis #EM #IM #PCC #Pleural #Effusion #Transudative #Exudative #Differential #Algorithm
Workup, Diagnostic Algorithm ... #Diagnosis #EM ... #IM #PCC #Pleural ... #Differential #Algorithm ... Lights #Criteria #Ddxof
Algorithm and Causes of an Elevated Hemidiaphragm #Diagnosis #Radiology #EM #IM #PCC #Elevated #Hemidiaphragm #ElevatedHemidiaphragm #Diaphragm
Algorithm and Causes ... Diagnosis #Radiology #EM ... #IM #PCC #Elevated ... #Differential #Algorithm ... #Ddxof
Differential Diagnosis of Hemoptysis #Diagnosis #EM #IM #InfectiousDisease #Pulmonary #Hemoptysis #Extrapulmonary #Differential #Algorithm #Assessment #Ddxof
Hemoptysis #Diagnosis #EM ... InfectiousDisease #Pulmonary ... #Differential #Algorithm ... #Assessment #Ddxof
Algorithm for Evaluation of Suspected Pulmonary Embolism #Diagnosis #EM #IM #PCC #PulmonaryEmbolism #Pulmonary #Embolism #DDimer #CTA
Algorithm for Evaluation ... of Suspected Pulmonary ... Embolism #Diagnosis #EM ... #IM #PCC #PulmonaryEmbolism ... #Ddxof
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... for the treatment ... of cancer-associated ... thrombosis; PE = pulmonary ... #Algorithm #Anticoagulation
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
Clindamycin in case of PCN ... hemorrhage • Treatment ... several months of treatment ... foreign body, cancer ... Lung #Abscess #pulmonary
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Lymphoma • Lung cancer ... staining, NAA (PCR ... Tuberculosis Treatment ... Initiating Treatment ... Diagnosis #Management #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Lymphoma • Lung cancer ... staining, NAA (PCR ... Tuberculosis Treatment ... Initiating Treatment ... Diagnosis #Management #Treatment